Klor-con and Atrioventricular block first degree - a phase IV clinical study of FDA data

Summary:

Atrioventricular block first degree is found among people who take Klor-con, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Klor-con and have Atrioventricular block first degree. It is created by eHealthMe based on reports of 24,920 people who have side effects when taking Klor-con from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 17, 2022

24,920 people reported to have side effects when taking Klor-con.
Among them, 63 people (0.25%) have Atrioventricular block first degree.


What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 24,534 Klor-con users for its effectiveness, alternative drugs and more.

What is Atrioventricular block first degree?

Atrioventricular block first degree (heart block first degree) is found to be associated with 1,279 drugs and 695 conditions by eHealthMe.

Number of Klor-con and Atrioventricular block first degree reports submitted per year:

Could Klor-con cause Atrioventricular block first degree?

Gender of people who have Atrioventricular block first degree when taking Klor-con *:

  • female: 38.1 %
  • male: 61.9 %

Age of people who have Atrioventricular block first degree when taking Klor-con *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 1.75 %
  • 40-49: 14.04 %
  • 50-59: 8.77 %
  • 60+: 75.44 %

Common drugs people take besides Klor-con *:

  1. Lasix: 33 people, 52.38%
  2. Digoxin: 30 people, 47.62%
  3. Furosemide: 30 people, 47.62%
  4. Ambien: 22 people, 34.92%
  5. Spironolactone: 20 people, 31.75%
  6. Coumadin: 19 people, 30.16%
  7. Coreg: 18 people, 28.57%
  8. Aldactone: 17 people, 26.98%
  9. Lisinopril: 17 people, 26.98%
  10. Synthroid: 17 people, 26.98%

Common side effects people have besides Atrioventricular block first degree *:

  1. Dizziness: 33 people, 52.38%
  2. Fall: 31 people, 49.21%
  3. Hypotension (abnormally low blood pressure): 30 people, 47.62%
  4. Breathing Difficulty: 30 people, 47.62%
  5. Cardiac Failure Congestive: 29 people, 46.03%
  6. Fatigue (feeling of tiredness): 27 people, 42.86%
  7. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 26 people, 41.27%
  8. Weakness: 25 people, 39.68%
  9. Weight Decreased: 24 people, 38.10%
  10. Pain: 22 people, 34.92%

Common conditions people have *:

  1. Metastases To Bone (cancer spreads to bone): 9 people, 14.29%
  2. Prostate Cancer: 8 people, 12.70%
  3. Cardiac Failure Congestive: 7 people, 11.11%
  4. Depression: 7 people, 11.11%
  5. Prothrombin Level Abnormal: 5 people, 7.94%
  6. Pain: 5 people, 7.94%
  7. Diabetes: 5 people, 7.94%
  8. Non-Hodgkin's Lymphoma Stage Iii (malignant (cancer) cells form in the lymph system- stage iii): 5 people, 7.94%
  9. Multiple Myeloma (cancer of the plasma cells): 4 people, 6.35%
  10. Insomnia (sleeplessness): 4 people, 6.35%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and have Atrioventricular block first degree?

Check whether Atrioventricular block first degree is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Atrioventricular block first degree and when was it recovered:

Expand to all the drugs that have ingredients of potassium chloride:

Alternative drugs to, pros and cons of Klor-con:

Common Klor-con side effects:

Browse all side effects of Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Atrioventricular block first degree treatments and more:

COVID vaccines that are related to Atrioventricular block first degree:

Common drugs associated with Atrioventricular block first degree:

All the drugs that are associated with Atrioventricular block first degree:

Common conditions associated with Atrioventricular block first degree:

All the conditions that are associated with Atrioventricular block first degree:

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Klor-con) and Klor-con (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: